{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:20:39Z","timestamp":1772688039015,"version":"3.50.1"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Inulin and its analog sinistrin are fructose polymers used in the food and pharmaceutical industries. In 2018, The French National Agency for the Safety of Medicines and Health Products (ANSM) decided to withdraw products containing sinistrin and inulin due to several reports of serious hypersensitivity reactions, including a fatal outcome.<\/jats:p><jats:p><jats:bold>Objective:<\/jats:bold> To assess the safety of inulin and sinistrin use in France.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold>: We searched multiple sources to identify adverse reactions (ARs) to inulin or sinistrin: first, classical pharmacovigilance databases including the French Pharmacovigilance (FPVD) and the WHO Database (VigiBase); second, data from a clinical trial, MultiGFR; third, data regarding current use in an hospital. All potential ARs to inulin or sinistrin were analyzed with a focus on hypersensitivity reactions and relationships to batches of sinistrin.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> From 1991 to 2018, 134 ARs to inulin or sinistrin were registered in the FPVD or VigiBase. Sixty-three cases (47%) were classified as serious, and 129 cases (96%) were hypersensitivity reactions. We found an association between a batch of sinistrin and the occurrence of hypersensitivity reactions. During the MultiGFR clinical trial, 7 patients (7\/163 participants) had an Adverse reaction; of these, 4 were hypersensitivity reactions including one case of grade 4 anaphylactic shock. In the hospital, no ARs were observed. In the literature, ARs to inulin and sinistrin are very rarely reported and mostly benign.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Most ARs to inulin and sinistrin are hypersensitivity reactions that appear to be associated with sinistrin batches.<\/jats:p>","DOI":"10.3389\/fphar.2021.725417","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T09:46:20Z","timestamp":1637228780000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Safety of Inulin and Sinistrin: Combining Several Sources for Pharmacovigilance Purposes"],"prefix":"10.3389","volume":"12","author":[{"given":"T-V.","family":"Bui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Prot-Bertoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ayari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-P.","family":"Bertocchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bureau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Houillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Prie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lillo-Le Louet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Courbebaisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1053\/j.ajkd.2008.06.008","article-title":"Hypersensitivity to Inulin: a Rare and Mostly Benign Event","volume":"52","author":"Bacchetta","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s00467-008-0819-9","article-title":"\u2018Renal Hypersensitivity' to Inulin and IgA Nephropathy","volume":"23","author":"Bacchetta","year":"2008","journal-title":"Pediatr. Nephrol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1258\/0004563021901621","article-title":"Anaphylactic Reaction to Intravenous Sinistrin (Inutest)","volume":"39","author":"Chandra","year":"2002","journal-title":"Ann. Clin. Biochem."},{"key":"B4","article-title":"\u00ab Guide de Bonnes Pratiques en Culture de Chicor\u00e9e Industrielle \u00bb","author":"Cornelis","year":"2013"},{"key":"B5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000083323","article-title":"Anaphylactic Reaction to Inulin: First Identification of Specific IgEs to an Inulin Protein Compound","volume":"136","author":"Franck","year":"2005","journal-title":"Int. Arch. Allergy Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1345\/aph.1E267","article-title":"Anaphylaxis to Intravenous Sinistrin","volume":"38","author":"Fux","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005043421814","article-title":"Anaphylaxis from Inulin in Vegetables and Processed Food","volume":"342","author":"Gay-Crosier","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"B8","volume-title":"Guideline on Good Pharmacovigilance Practices (GVP) \u2013 Annex I (Rev 4)","year":"2011"},{"key":"B9","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.amjmed.2013.09.008","article-title":"Recognition and First-Line Treatment of Anaphylaxis. Epub 2013 Oct 1. PMID: 24384138","volume":"127","author":"Lieberman","year":"2014","journal-title":"Am. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.carbpol.2015.05.026","article-title":"Inulin, a Flexible Oligosaccharide I: Review of its Physicochemical Characteristics","volume":"130","author":"Mensink","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"B11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.carbpol.2015.08.0224","article-title":"Inulin, a Flexible Oligosaccharide. II: Review of its Pharmaceutical Applications","volume":"134","author":"Mensink","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"B12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ab.2004.03.019","article-title":"Quantitative Analysis of Sinistrin in Serum with High-Performance Liquid Chromatography for Renal Function Testing","volume":"331","author":"Oettl","year":"2004","journal-title":"Anal. Biochem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/bcp.12198","article-title":"Measurement of Renal Function in Patients with Chronic Kidney Disease","volume":"76","author":"Sandilands","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.carbpol.2016.04.020","article-title":"Inulin: Properties, Health Benefits and Food Applications","volume":"147","author":"Shoaib","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"B15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0008-6215(92)80090-N","article-title":"The Structure of the Fructan Sinistrin from Urginea Maritima","volume":"235","author":"Spies","year":"1992","journal-title":"Carbohydr. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.725417\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T09:46:23Z","timestamp":1637228783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.725417\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":15,"alternative-id":["10.3389\/fphar.2021.725417"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.725417","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"article-number":"725417"}}